Abstract
In this issue of Blood, Pievani et al have identified a potential solution to the remaining barrier to the success of hematopoietic stem cell transplantation (HSCT) in children with severe phenotype Hurler syndrome (mucopolysaccharidosis type I [MPS I]).1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for freeCite
CITATION STYLE
APA
Kurtzberg, J. (2015, March 5). Early HSCT corrects the skeleton in MPS. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-11-606681
Readers' Seniority
Readers' Discipline
